RU94023697A - Method for treating early age children possessing infectious toxicosis
- Google Patents
Method for treating early age children possessing infectious toxicosis
Info
Publication number
RU94023697A
RU94023697ARU94023697/14ARU94023697ARU94023697ARU 94023697 ARU94023697 ARU 94023697ARU 94023697/14 ARU94023697/14 ARU 94023697/14ARU 94023697 ARU94023697 ARU 94023697ARU 94023697 ARU94023697 ARU 94023697A
Ивановский государственный медицинский институт им. А.С.Бубнова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ивановский государственный медицинский институт им. А.С.БубноваfiledCriticalИвановский государственный медицинский институт им. А.С.Бубнова
Priority to RU94023697ApriorityCriticalpatent/RU2090189C1/en
Publication of RU94023697ApublicationCriticalpatent/RU94023697A/en
Application grantedgrantedCritical
Publication of RU2090189C1publicationCriticalpatent/RU2090189C1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
FIELD: medicine. SUBSTANCE: method involves intravenously administering Cavinton at a dose of 1 mg/kg daily. EFFECT: prevented vital complications; accelerated treatment course.
Claims (1)
В качестве средства для лечения инфекционного токсикоза используют кавинтон 1 мг/кг в сутки внутривенно капельно со скоростью 6 кап./мин. Это предупреждает развитие витальных осложнений, сокращает срок пребывания в отделении интенсивной терапии, снижает инвалидизацию.Cavinton 1 mg / kg per day is used as an agent for the treatment of infectious toxicosis intravenously at a rate of 6 drops / min. This prevents the development of vital complications, reduces the length of stay in the intensive care unit, and reduces disability.
RU94023697A1994-06-231994-06-23Agent for treatment of infectious toxicosis of infants
RU2090189C1
(en)
THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA
The application of anticonvulsive agents for the preparation of medicaments intended for treating parkinson's disease and parkinson's syndromes